ASP-2390(Immunomic Therapeutics)
N/A
Report date: 2025/04/20 20:00:03
Base Information
Drug NameASP-2390(Immunomic Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesAstellas Pharma Global Development Inc
Inactive CompaniesAstellas Pharma Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A